Oct 24, 2023 / 11:00AM GMT
Presentation
Oct 24, 2023 / 11:00AM GMT
=====================
Corporate Participants
=====================
* Jeff Legos
Novartis AG - Senior VP & Global Program Head of Oncology
* Samir Shah
Novartis AG - Global Head of IR
* Shreeram Aradhye
Novartis AG - President of Global Drug Development & Chief Medical Officer
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Gary Steventon
BNP Paribas Exane, Research Division - Research Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst
* Michael Thomas Nedelcovych
TD Cowen, Research Division - Research Associate
* Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst & European Pharmaceuticals Analyst
*
Novartis AG
(FRA:NOT)
€
131.52
+2.76 (+2.14%)
Market Cap: 254.78 Bil
Enterprise Value: 290.16 Bil
PE Ratio: 22.13
PB Ratio: 7.77
GF Score: 83/100 Novartis AG PSMAfore Data at ESMO Presentation Transcript
Oct 24, 2023 / 11:00AM GMT
Release Date Price:
€75.17
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot